EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study

Amr M Ammar, Ibrahim S Ibrahim, Abbas N Mohamed, Mohamed L Elsaie

Irish Journal of Medical Science (1971 -) · 2024

DOI: 10.1007/s11845-023-03493-5 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Irish Journal of Medical Science (1971 -), 2024. Verfasst von Amr M Ammar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Andrology, Al-Azhar University, Cairo, Egypt. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Centre Egypt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abstact Background Coronavirus disease (COVID-19) currently named SARS-CoV-2 is a contagious disease caused by a coronavirus; incompatible data are present on the possible relationship among COVID-19 vaccines and hair loss.

Aims

The objective of the current study was to assess dermoscopically the prevalence of hair loss among an Egyptian population following COVID-19 vaccination.

Methods

A total of 2000 participants were enrolled in this cross-sectional study. Adult males and females who received one of recognized COVID-19 vaccine were included, irrespective of the status of previous COVID-19 infection. Those who were aged less than 18 years or above 60 years were excluded. Furthermore, subjects self-reporting hair loss were assessed by dermoscopy.

Results

Among the studied cases, n = 478 (23.9%) complained of hair loss following vaccination. The majority of cases noticed their hair loss during the first 2 months post-vaccination (n = 215 after the first month and n = 158 after the 2nd month respectively).

Conclusion

We reported prevalence of post-vaccination hair fall that was confirmed by trichoscopy and which affected approximately one quarter of participants who received COVID-19 vaccines. Other factors, such as stress and infection, cannot be excluded and remain to be further investigated by larger multicenter studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19AdultMaleFemaleHumansCross-Sectional StudiesDermoscopyEgyptPrevalenceSARS-CoV-2AlopeciaVaccination

Stichwörter der Autor:innen

AlopeciaTelogen effluviumTrichoscopy

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Andrology, Al-Azhar University, Cairo, Egypt.
  • Department of Dermatology, Venereology and Andrology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. Egydoc77@yahoo.com.

Förderung

  • National Research Centre Egypt

Zitieren

APA

Ammar, A. M., Ibrahim, I. S., Mohamed, A. N., & Elsaie, M. L. (2024). Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-023-03493-5

Vancouver

Ammar AM, Ibrahim IS, Mohamed AN, Elsaie ML. Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study. Irish Journal of Medical Science (1971 -). 2024. doi:10.1007/s11845-023-03493-5

BibTeX
@article{Ammar2024,
  author = {Ammar, Amr M and Ibrahim, Ibrahim S and Mohamed, Abbas N and Elsaie, Mohamed L},
  title = {Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study},
  journal = {Irish Journal of Medical Science (1971 -)},
  year = {2024},
  doi = {10.1007/s11845-023-03493-5}
}
Kostenlos starten →